|
Foxo Technologies Inc (NYSEAMER: FOXO) |
|
Foxo Technologies Inc
FOXO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Foxo Technologies Inc growth rates, revenue grew
by 9100 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2013
Medical Laboratories industry recorded
growth of revenues by 6.58 %
Foxo Technologies Inc net loss decreased from $-8 millions, to $-2 millions in III. Quarter 2024,
• More on FOXO's Growth
|
|
Foxo Technologies Inc realized a net loss in trailing twelve months.
Foxo Technologies Inc realized cash reduction of $ -0.16 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 1.62.
Medical Laboratories industry's Price to Sales ratio is at 2.33.
• More on FOXO's Valuation
|
|
|
|
|
Foxo Technologies Inc realized net loss in trailing twelve months.
Foxo Technologies Inc realized cash outflow of $ -0.16per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 1.62.
Medical Laboratories industry's Price to Sales ratio is at 2.33.
• More on FOXO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com